The federal government needs to support an inclusive engineering biology ecosystem that leverages Canadian-grown capacities across industry, academia and government, Bettina Hamelin, president and CEO of Ontario Genomics, says in an editorial. Canada needs a comprehensive and aligned roadmap for a public-private partnership and investment strategy to benefit from the increasing opportunities in this emerging sector, she says.
Topic: biotechnology
adMare BioInnovations launches back-to-back biotech companies
Formed in 2019 from a union of the Centre for Drug Research and Development (CDRD) and the NEOMED Institute, adMare Bioinnovations has already launched 10 companies to date.
Vancouver biotech firm AbCellera wins SIF research funding to fast-track antibody therapies against COVID-19
Vancouver-based biotech firm AbCellera, using its technology spun off research at University of British Columbia, is fast-tracking testing and clinical trials of therapeutic antibodies against COVID-19.
Global community confronts the implications of human genome editing
The WHO has launched a global registry to track research on human genome editing—the first concrete recommendation of an advisory committee charged with determining what an effective oversight and governance framework should look like in the CRISPR era. At the same time, medical and scientific societies in other nations are grappling with the unprecedented ethical and scientific implications of altering the human genome in future generations.
Alberta invests $100M in innovative clean tech projects
Emissions Reduction Alberta invests $100 million in 16 new clean tech projects in the areas of sustainable transportation, electricity and biotechnology.